To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds
Journal:
Current Medicinal Chemistry
Volume:
31
Page:
3752-3790
Author(s):
Banani Bhattacharjee, Arnob Chakrovorty, Maharaj Biswas*, Asmita Samadder* and Sisir Nandi*
Association of COVID with Mycosis in General
Journal:
Infectious Disorders - Drug Targets
Volume:
24
Page:
13-21
Author(s):
Gurpreet Kaur, Rajinder Kaur*, Sumanpreet and Manpreet Kaur
Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?
Journal:
Current Pharmaceutical Design
Volume:
30
Page:
1149-1156
Author(s):
Medine Cumhur Cure and Erkan Cure*
Ketosis-prone Diabetes Presenting with Acute Esophageal Necrosis or “Black Esophagus”: An Intriguing New Clinical Association
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
24
Page:
857-863
Author(s):
Riccardo Maria Pollis, Damiano Furlanetto, Elena Pagin, Carla Scaroni, Mattia Barbot and Giacomo Voltan*
Body Fat Distribution Contributes to Defining the Relationship between Insulin Resistance and Obesity in Human Diseases
Journal:
Current Diabetes Reviews
Volume:
20
Page:
66-96
Author(s):
María M. Adeva-Andany*, Alberto Domínguez-Montero, Lucía Adeva-Contreras, Carlos Fernández-Fernández, Natalia Carneiro-Freire and Manuel González-Lucán
Alkaloids as Promising Agents for the Management of Insulin Resistance: A Review
Journal:
Current Pharmaceutical Design
Volume:
29
Page:
3123-3136
Author(s):
Ayoub Amssayef and Mohamed Eddouks*
The Effects of Obesity on Bone Turnover Markers in Diabetic Patients with Diabetic Ketosis or Ketoacidosis
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
23
Page:
1660-1667
Author(s):
Min Gong, Chenglin Xu, Song Wen*, Yue Yuan, Liling Yang, Mingyue Zhou, Yanyan Li and Ligang Zhou*
Mucormycosis: A Serious Catastrophe Involving COVID-19 Patients
Journal:
Coronaviruses
Volume:
4
Page:
68-73
Author(s):
Neha Dangi, Himanshu Mehendiratta and Shikha Sharma*
Ketosis-prone Diabetes and Hypogonadism: A New Clinical Association to be Aware of ?
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
23
Page:
1552-1556
Author(s):
Andrea Graziani, Riccardo Maria Pollis*, Benedetta Maria Bonora, Carla Scaroni and Chiara Sabbadin
Renal Protection and Safety of Sodium-glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease
Journal:
Current Pharmaceutical Design
Volume:
29
Page:
1659-1670
Author(s):
Tianbiao Zhou*, Kaijin Yao, Yina Xie, Yongda Lin, Jiali Wang and Xiutian Chen